These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10354361)

  • 1. Targeting the skin for genetic immunization.
    Falo LD
    Proc Assoc Am Physicians; 1999; 111(3):211-9. PubMed ID: 10354361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating and regulating immune responses through cutaneous gene delivery.
    Larregina AT; Falo LD
    Hum Gene Ther; 2000 Nov; 11(16):2301-5. PubMed ID: 11084690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA immunization targeting the skin: molecular control of adaptive immunity.
    Tüting T; Storkus WJ; Falo LD
    J Invest Dermatol; 1998 Aug; 111(2):183-8. PubMed ID: 9699714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-based strategies for the immunotherapy of cancer.
    Tüting T; Storkus WJ; Lotze MT
    J Mol Med (Berl); 1997 Jul; 75(7):478-91. PubMed ID: 9253711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection.
    Dupré L; Kremer L; Wolowczuk I; Riveau G; Capron A; Locht C
    Vaccine; 2001 Jan; 19(11-12):1373-80. PubMed ID: 11163659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the mucosa: genetically engineered vaccines and mucosal immune responses.
    Stevceva L; Abimiku AG; Franchini G
    Genes Immun; 2000 Jun; 1(5):308-15. PubMed ID: 11196691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccination: antigen presentation and the induction of immunity.
    Shedlock DJ; Weiner DB
    J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating the immune response to genetic immunization.
    Cohen AD; Boyer JD; Weiner DB
    FASEB J; 1998 Dec; 12(15):1611-26. PubMed ID: 9837851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production.
    Asakura Y; Liu LJ; Shono N; Hinkula J; Kjerrström A; Aoki I; Okuda K; Wahren B; Fukushima J
    Clin Exp Immunol; 2000 Jan; 119(1):130-9. PubMed ID: 10606974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunology of cutaneous DNA immunization.
    Tüting T
    Curr Opin Mol Ther; 1999 Apr; 1(2):216-25. PubMed ID: 11715945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.
    Porgador A; Irvine KR; Iwasaki A; Barber BH; Restifo NP; Germain RN
    J Exp Med; 1998 Sep; 188(6):1075-82. PubMed ID: 9743526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA gene fusion vaccines against cancer.
    Zhu D; Stevenson FK
    Curr Opin Mol Ther; 2002 Feb; 4(1):41-8. PubMed ID: 11883694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.
    Sudowe S; Dominitzki S; Montermann E; Bros M; Grabbe S; Reske-Kunz AB
    Immunology; 2009 Sep; 128(1 Suppl):e193-205. PubMed ID: 18800984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing immune responses with genetic immunization and immunostimulatory DNA sequences.
    Thalhamer J; Leitner W; Hammerl P; Brtko J
    Endocr Regul; 2001 Sep; 35(3):143-66. PubMed ID: 11674843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble cytokines can act as effective adjuvants in plasmid DNA vaccines targeting self tumor antigens.
    Disis ML; Shiota FM; McNeel DG; Knutson KL
    Immunobiology; 2003; 207(3):179-86. PubMed ID: 12777059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal naked plasmid DNA immunization: mechanisms of action.
    Elnekave M; Furmanov K; Hovav AH
    Expert Rev Vaccines; 2011 Aug; 10(8):1169-82. PubMed ID: 21854310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
    Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivector.
    He Y; Falo LD
    Immunol Res; 2006; 36(1-3):101-17. PubMed ID: 17337771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.
    Gaffal E; Schweichel D; Tormo D; Steitz J; Lenz J; Basner-Tschakarjan E; Limmer A; Tüting T
    Eur J Cell Biol; 2007 Dec; 86(11-12):817-26. PubMed ID: 16928407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.